Metsera, Inc. 3 SEC Filings

Filed On	Filing
30 Apr 2025	Form 3: Lang Matthew, Chief Legal Officer
30 Apr 2025	Form 3: Stonehouse Jon P, Director No securities owned
30 Jan 2025	Form 3: Burow Kristina, Director Holds 1,063,955 shares of Common Stock
30 Jan 2025	Form 3: Marso Steven, Chief Medical Officer
30 Jan 2025	Form 3: Berns Paul L, Director Holds 957,559 shares of Common Stock
30 Jan 2025	Form 3: Validae Health, L.p., 10% owner and 1 other Holds 12,767,462 shares of Common Stock
30 Jan 2025	Form 3: Visioli Christopher, Chief Financial Officer
30 Jan 2025	Form 3: Hubbard Brian, Chief Scientific Officer
30 Jan 2025	Form 3: Meanwell Clive, Director Holds 12,767,462 shares of Common Stock
30 Jan 2025	Form 3: Bernard Christopher Whitten, Director Holds 12,767,462 shares of Common Stock
30 Jan 2025	Form 3: Pinto Joshua, Director
30 Jan 2025	Form 3: Arch Venture Partners XII, Llc, 10% owner and 8 others Holds 1,063,955 shares of Common Stock
30 Jan 2025	Form 3: Wellington Biomedical Innovation Master Investors (Cayman) Ii L.p., 10% owner
30 Jan 2025	Form 3: Fmr Llc, 10% owner

Comments